FIRST TRUST ADVISORS LP - LIGAND PHARMACEUTICALS INC ownership

LIGAND PHARMACEUTICALS INC's ticker is LGND and the CUSIP is 53220K504. A total of 269 filers reported holding LIGAND PHARMACEUTICALS INC in Q2 2016. The put-call ratio across all filers is 2.47 and the average weighting 0.4%.

Quarter-by-quarter ownership
FIRST TRUST ADVISORS LP ownership history of LIGAND PHARMACEUTICALS INC
ValueSharesWeighting
Q3 2023$1,075,863
-13.7%
17,955
+5.9%
0.00%0.0%
Q1 2023$1,247,209
+336.4%
16,955
+296.3%
0.00%
Q4 2022$285,770
-69.8%
4,278
-61.1%
0.00%
-100.0%
Q3 2022$947,000
-23.3%
10,999
-20.5%
0.00%
-50.0%
Q2 2022$1,234,000
+38.0%
13,832
+74.0%
0.00%
+100.0%
Q1 2022$894,000
+35.5%
7,949
+86.2%
0.00%0.0%
Q4 2021$660,000
-62.2%
4,270
-66.0%
0.00%
-50.0%
Q3 2021$1,748,000
-58.5%
12,549
-60.9%
0.00%
-60.0%
Q2 2021$4,215,000
+596.7%
32,126
+428.0%
0.01%
+400.0%
Q4 2020$605,000
-67.3%
6,084
-68.6%
0.00%
-66.7%
Q3 2020$1,848,000
-33.6%
19,386
-5.6%
0.00%
-57.1%
Q4 2018$2,785,000
-64.7%
20,526
-28.6%
0.01%
-53.3%
Q3 2018$7,893,000
+67.4%
28,756
+26.3%
0.02%
+50.0%
Q2 2018$4,715,000
+127.6%
22,760
+81.5%
0.01%
+100.0%
Q1 2018$2,072,000
+21.0%
12,543
+0.2%
0.01%
+25.0%
Q4 2017$1,713,000
+5.7%
12,513
+5.1%
0.00%0.0%
Q3 2017$1,621,000
+209.4%
11,904
+175.6%
0.00%
+300.0%
Q2 2017$524,000
-76.0%
4,320
-79.8%
0.00%
-85.7%
Q3 2016$2,179,000
+8.4%
21,352
+26.6%
0.01%
+16.7%
Q2 2016$2,011,000
-6.6%
16,865
-16.1%
0.01%
-14.3%
Q1 2016$2,154,000
-2.4%
20,110
-1.2%
0.01%
+16.7%
Q4 2015$2,207,000
-22.1%
20,358
-38.5%
0.01%
-25.0%
Q3 2015$2,834,000
-22.2%
33,091
-8.3%
0.01%
-11.1%
Q2 2015$3,641,000
+211.7%
36,090
+45.2%
0.01%
+80.0%
Q3 2014$1,168,000
-48.7%
24,859
-32.0%
0.01%
-44.4%
Q2 2014$2,279,000
-12.3%
36,579
-5.3%
0.01%
-18.2%
Q1 2014$2,600,00038,6450.01%
Other shareholders
LIGAND PHARMACEUTICALS INC shareholders Q2 2016
NameSharesValueWeighting ↓
KNOTT DAVID M 353,041$36,819,00014.92%
CARDINAL CAPITAL MANAGEMENT LLC /CT 919,994$95,946,0002.93%
Elk Creek Partners, LLC 236,862$24,702,0002.84%
Conestoga Capital Advisors, LLC 619,653$64,624,0001.56%
WOODSTOCK CORP 71,489$7,456,0001.21%
Summit Creek Advisors LLC 70,962$7,401,0001.16%
FALCON POINT CAPITAL, LLC 8,115$846,0001.08%
RICE HALL JAMES & ASSOCIATES, LLC 302,503$31,548,0001.07%
Stephens Investment Management Group LLC 508,100$52,990,0001.00%
Tygh Capital Management, Inc. 55,672$5,806,0000.96%
View complete list of LIGAND PHARMACEUTICALS INC shareholders